Serving Whom?
GRACE: Global Review of AI Community Ethics · 27.03.2025
DOI: 10.60690/v4rcyz59 ↗Kurz gefasst
Fachartikel in der Zeitschrift GRACE: Global Review of AI Community Ethics, erschienen am 27.03.2025. Verfasst von Falade und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
AI mental health chatbots could offer a promising solution to the care gap faced by underserved communities, especially during times of social isolation and health crisis. These tools provide round-the-clock, low-cost, and stigma-free support. Yet, this paper explores how current implementations face challenges that may limit their long-term efficacy and equitable impact. Drawing on recent empirical studies and ethical scholarship, I evaluate the capabilities and constraints of AI chatbots as short-term mental health supports and propose safeguards that promote inclusive, culturally relevant, and ethically responsible deployment. This study presents new empirical insights from a qualitative interview study with 18 low-income, first-generation community college students of color, whose reflections on chatbot use underscore the importance of trust, cultural resonance, and long-term engagement. Rather than comparing or critiquing specific products, this research centers community voices and advocates for collaborative, community-informed improvement. It also draws from an ethically sourced and protected dataset created by Dr. Harriett Jernigan at Stanford University, which provides a compelling counterexample of culturally specific chatbot design.
Schlagwörter
Zitieren
APA
Falade, & Omotunde (2025). Serving Whom?. GRACE: Global Review of AI Community Ethics. https://doi.org/10.60690/v4rcyz59
Vancouver
Falade, Omotunde. Serving Whom?. GRACE: Global Review of AI Community Ethics. 2025. doi:10.60690/v4rcyz59
BibTeX
@article{Falade2025,
author = {Falade and Omotunde},
title = {Serving Whom?},
journal = {GRACE: Global Review of AI Community Ethics},
year = {2025},
doi = {10.60690/v4rcyz59}
}
EUVIMED